Tracking Elusive Breast Cancer Cells
New research by PerkinElmer confirms that PD-L1 protein expression levels in human breast cancer cells can be quickly and accurately assessed directly with the AlphaLISA human PD-L1 assay.
High Content Screening System Helps Discover New Cancer Immunotherapies And Advance Personalized Medicine
Using a PerkinElmer Opera Phenix Imaging System and proprietary analytic algorithms, a team of Austrian scientists developed Pharmacoscopy, a method to rapidly screen existing drugs for potential use in cancer immunotherapy.
Innovators in Cancer Immunology: Ovarian Cancer
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In an ovarian cancer case study, Dr. Feldman uses this instrumentation to modernize pathology.
Innovators in Cancer Immunology: Squamous Cell Carcinoma
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a squamous cell carcinoma cancer case study, Dr. Fox uses the instrumentation to help develop predictive biomarkers.
Innovators in Cancer Immunology: Lymphoma
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a lymphoma cancer case study, Dr. Rodig uses the instrumentation to gain insight into tumor pathogenesis.
Innovators in Cancer Immunology: Lung Cancer
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a lung cancer case study, Dr. Rimm uses this instrumentation to evaluate tumor infiltrating lymphocytes.
Innovators in Cancer Immunology: Colorectal Cancer
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a colorectal case study, Dr. Galon uses this instrumentation to uncover more details about cancer and the immune system.
Innovators in Cancer Immunology: Breast Cancer
Cancer researchers are uncovering new insights using our Phenoptics™ Quantitative Pathology Research Solutions. In a breast cancer case study, Dr. Rimm uses this instrumentation in her immune-oncology research.
AMRI/PerkinElmer Collaboration Is Advancing Precision Medicine
Two years after forming a strategic collaboration AMRI and PerkinElmer are helping to eliminate research and clinical data silos and advance precision medicine.
PerkinElmer’s High-Content Imaging System Reveals Secrets of Tuberculosis
Research at Institut Pasteur de Lille using PerkinElmer’s Opera® High-Content Screening System and Acapella® Image Analysis Software contributes substantial new information to our understanding of M. tuberculosis.